Latest Breaking News On - Andrew hamer - Page 2 : comparemela.com

Cardiol Therapeutics wraps up patient enrollment for Phase II open label study

Cardiol Therapeutics wraps up patient enrollment for Phase II open label study
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew hamerCardiol therapeuticsOrphan drug designation

Cannabidiol Formulation Granted Orphan Drug Designation for Pericarditis

The tolerance, safety, and effect of CardiolRx in patients with recurrent pericarditis is currently being investigated in the phase 2, open-label MAvERIC-Pilot study.

Andrew hamerHead of research developmentDrug administrationOrphan drugCardiol therapeutic chief medical officer

Cardiol Therapeutics Inc : Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Cardiol Therapeutics Inc : Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesAndrew hamerStefan klotterTrevor burnsCardiol therapeutics incNewsfile corpHead of research developmentCompany annual report on formDrug administrationCompany phaseDesignated newsUnited states foodOrphan drug designationPilot phaseCardiol therapeutic chief medical officerFast track

Cardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of Pericarditis

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart.

United statesAndrew hamerTrevor burnsCompany phaseCardiol therapeutics incHead of research developmentNewsfile corpCompany annual report on formDrug administrationDesignated newsUnited states foodOrphan drug designationPilot phaseCardiol therapeutic chief medical officerFast trackBreakthrough therapy

Cardiol Therapeutics (CRDL) Granted FDA Orphan Drug Designation for Pericarditis

Cardiol Therapeutics (CRDL) Granted FDA Orphan Drug Designation for Pericarditis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew hamerCardiol therapeutics incCompany phaseHead of research developmentDrug administrationCardiol therapeuticsUnited states foodOrphan drug designationPilot phaseCardiol therapeutic chief medical officerFast trackBreakthrough therapyPriority review